Deployment of Artificial Intelligence in Real-World Practice: Opportunity and Challenge

被引:36
作者
He, Mingguang [1 ,2 ]
Li, Zhixi [1 ]
Liu, Chi [1 ,3 ]
Shi, Danli [1 ]
Tan, Zachary [4 ,5 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China
[2] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3003, Australia
[3] Univ Technol Sydney, Sch Comp Sci, Ultimo, NSW, Australia
[4] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[5] Tsinghua Univ, Schwarzman Coll, Beijing, Peoples R China
来源
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY | 2020年 / 9卷 / 04期
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
artificial intelligence; deployment; real-world; GLAUCOMATOUS OPTIC NEUROPATHY; DIABETIC-RETINOPATHY; COHERENCE TOMOGRAPHY; AUTOMATED IDENTIFICATION; FUNDUS PHOTOGRAPHS; EVALUATION PROJECT; DEEP; VALIDATION; ACCURACY; PREDICTION;
D O I
10.1097/APO.0000000000000301
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Artificial intelligence has rapidly evolved from the experimental phase to the implementation phase in many image-driven clinical disciplines, including ophthalmology. A combination of the increasing availability of large datasets and computing power with revolutionary progress in deep learning has created unprecedented opportunities for major breakthrough improvements in the performance and accuracy of automated diagnoses that primarily focus on image recognition and feature detection. Such an automated disease classification would significantly improve the accessibility, efficiency, and cost-effectiveness of eye care systems where it is less dependent on human input, potentially enabling diagnosis to be cheaper, quicker, and more consistent. Although this technology will have a profound impact on clinical flow and practice patterns sooner or later, translating such a technology into clinical practice is challenging and requires similar levels of accountability and effectiveness as any new medication or medical device due to the potential problems of bias, and ethical, medical, and legal issues that might arise. The objective of this review is to summarize the opportunities and challenges of this transition and to facilitate the integration of artificial intelligence (AI) into routine clinical practice based on our best understanding and experience in this area.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 88 条
[1]   Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices [J].
Abramoff, Michael D. ;
Lavin, Philip T. ;
Birch, Michele ;
Shah, Nilay ;
Folk, James C. .
NPJ DIGITAL MEDICINE, 2018, 1
[2]   Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning [J].
Abramoff, Michael David ;
Lou, Yiyue ;
Erginay, Ali ;
Clarida, Warren ;
Amelon, Ryan ;
Folk, James C. ;
Niemeijer, Meindert .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (13) :5200-5206
[3]   Threat of Adversarial Attacks on Deep Learning in Computer Vision: A Survey [J].
Akhtar, Naveed ;
Mian, Ajmal .
IEEE ACCESS, 2018, 6 :14410-14430
[4]  
[Anonymous], 2018, FDA PERM MARK CLIN D
[5]  
[Anonymous], 2018, FDA PERM MARK ART IN
[6]  
[Anonymous], 2018, DE NOVO CLASSIFICATI
[7]  
[Anonymous], 2018, SOFTW MED DEV
[8]  
[Anonymous], 2015, JAMA J AM MED ASSOC, DOI DOI 10.1001/JAMA.2015.1405
[9]   Deep learning algorithm predicts diabetic retinopathy progression in individual patients [J].
Arcadu, Filippo ;
Benmansour, Fethallah ;
Maunz, Andreas ;
Willis, Jeff ;
Haskova, Zdenka ;
Prunotto, Marco .
NPJ DIGITAL MEDICINE, 2019, 2 (1)
[10]   Detecting Preperimetric Glaucoma with Standard Automated Perimetry Using a Deep Learning Classifier [J].
Asaoka, Ryo ;
Murata, Hiroshi ;
Iwase, Aiko ;
Araie, Makoto .
OPHTHALMOLOGY, 2016, 123 (09) :1974-1980